– Interview with Keith Garrison, Ph.D., post-doctoral fellow in UCSF’s Division of Experimental Medicine

Previous articleAdolor Could Earn $264M in Pain Deal with Pfizer
Next articlePTC and Spinal Muscular Atrophy Foundation Extend Agreement